These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 32365944)

  • 1. SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation.
    Chang YS; Ko BH; Ju JC; Chang HH; Huang SH; Lin CW
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein.
    Yalcinkaya M; Liu W; Islam MN; Kotini AG; Gusarova GA; Fidler TP; Papapetrou EP; Bhattacharya J; Wang N; Tall AR
    Sci Rep; 2021 Dec; 11(1):24432. PubMed ID: 34952919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
    Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
    Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC.
    Siu KL; Yuen KS; Castaño-Rodriguez C; Ye ZW; Yeung ML; Fung SY; Yuan S; Chan CP; Yuen KY; Enjuanes L; Jin DY
    FASEB J; 2019 Aug; 33(8):8865-8877. PubMed ID: 31034780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1R and Inflammasomes Mediate Early Pulmonary Protective Mechanisms in Respiratory
    Hielpos MS; Fernández AG; Falivene J; Alonso Paiva IM; Muñoz González F; Ferrero MC; Campos PC; Vieira AT; Oliveira SC; Baldi PC
    Front Cell Infect Microbiol; 2018; 8():391. PubMed ID: 30456207
    [No Abstract]   [Full Text] [Related]  

  • 6. SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation.
    Pan P; Shen M; Yu Z; Ge W; Chen K; Tian M; Xiao F; Wang Z; Wang J; Jia Y; Wang W; Wan P; Zhang J; Chen W; Lei Z; Chen X; Luo Z; Zhang Q; Xu M; Li G; Li Y; Wu J
    Nat Commun; 2021 Aug; 12(1):4664. PubMed ID: 34341353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bystander monocytic cells drive infection-independent NLRP3 inflammasome response to SARS-CoV-2.
    Hsieh LL; Looney M; Figueroa A; Massaccesi G; Stavrakis G; Anaya EU; D'Alessio FR; Ordonez AA; Pekosz AS; DeFilippis VR; Karakousis PC; Karaba AH; Cox AL
    mBio; 2024 Oct; 15(10):e0081024. PubMed ID: 39240187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19.
    Yong YY; Zhang L; Hu YJ; Wu JM; Yan L; Pan YR; Tang Y; Yu L; Law BY; Yu CL; Zhou J; Li M; Qin DL; Zhou XG; Wu AG
    Clin Immunol; 2022 Nov; 244():109093. PubMed ID: 35944881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1.
    Ma-Lauer Y; Carbajo-Lozoya J; Hein MY; Müller MA; Deng W; Lei J; Meyer B; Kusov Y; von Brunn B; Bairad DR; Hünten S; Drosten C; Hermeking H; Leonhardt H; Mann M; Hilgenfeld R; von Brunn A
    Proc Natl Acad Sci U S A; 2016 Aug; 113(35):E5192-201. PubMed ID: 27519799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
    Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M
    Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice.
    Zeng J; Xie X; Feng XL; Xu L; Han JB; Yu D; Zou QC; Liu Q; Li X; Ma G; Li MH; Yao YG
    EBioMedicine; 2022 Jan; 75():103803. PubMed ID: 34979342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the NLRP3 Inflammasome in Severe COVID-19.
    Freeman TL; Swartz TH
    Front Immunol; 2020; 11():1518. PubMed ID: 32655582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventilator-induced lung injury is mediated by the NLRP3 inflammasome.
    Kuipers MT; Aslami H; Janczy JR; van der Sluijs KF; Vlaar AP; Wolthuis EK; Choi G; Roelofs JJ; Flavell RA; Sutterwala FS; Bresser P; Leemans JC; van der Poll T; Schultz MJ; Wieland CW
    Anesthesiology; 2012 May; 116(5):1104-15. PubMed ID: 22531249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glyburide attenuates ozone-induced pulmonary inflammation and injury by blocking the NLRP3 inflammasome.
    Shao H; Huang L; Duan S; Gao M; Zhu J; Chen X; Zhu Y; Wang W; Yang Z; Wang X; Wang Z; Wang Z; Ba Y; Zhang R; Li C; Zhang Q; Wang J; Liu H; Wu W; Feng F
    Environ Toxicol; 2020 Aug; 35(8):831-839. PubMed ID: 32167222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-Dependent Susceptibility to Pulmonary Fibrosis Is Associated with NLRP3 Inflammasome Activation.
    Stout-Delgado HW; Cho SJ; Chu SG; Mitzel DN; Villalba J; El-Chemaly S; Ryter SW; Choi AM; Rosas IO
    Am J Respir Cell Mol Biol; 2016 Aug; 55(2):252-63. PubMed ID: 26933834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma-derived exosomes contribute to pancreatitis-associated lung injury by triggering NLRP3-dependent pyroptosis in alveolar macrophages.
    Wu XB; Sun HY; Luo ZL; Cheng L; Duan XM; Ren JD
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165685. PubMed ID: 31953217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment.
    Bertoni A; Penco F; Mollica H; Bocca P; Prigione I; Corcione A; Cangelosi D; Schena F; Del Zotto G; Amaro A; Paladino N; Pontali E; Feasi M; Signa S; Bustaffa M; Caorsi R; Palmeri S; Contini P; De Palma R; Pfeffer U; Uva P; Rubartelli A; Gattorno M; Volpi S
    J Allergy Clin Immunol; 2022 Oct; 150(4):796-805. PubMed ID: 35835255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies.
    Zhao N; Di B; Xu LL
    Cytokine Growth Factor Rev; 2021 Oct; 61():2-15. PubMed ID: 34183243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection.
    Lécuyer D; Nardacci R; Tannous D; Gutierrez-Mateyron E; Deva Nathan A; Subra F; Di Primio C; Quaranta P; Petit V; Richetta C; Mostefa-Kara A; Del Nonno F; Falasca L; Marlin R; Maisonnasse P; Delahousse J; Pascaud J; Deprez E; Naigeon M; Chaput N; Paci A; Saada V; Ghez D; Mariette X; Costa M; Pistello M; Allouch A; Delelis O; Piacentini M; Le Grand R; Perfettini JL
    Front Immunol; 2023; 14():1270081. PubMed ID: 37920468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulatory Exosomes from COVID-19 Patients Trigger NLRP3 Inflammasome in Endothelial Cells.
    Sur S; Steele R; Isbell TS; Ray R; Ray RB
    mBio; 2022 Jun; 13(3):e0095122. PubMed ID: 35587188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.